Shiyang Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shiyang Sun has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Chunlai Jiang
National Engineering Laboratory for AIDS Vaccine, School of Life Science, Jilin University, Changchun, China
3 shared publications - Dong An
School of Life Sciences, Jilin University, Changchun 130012, China
3 shared publications - Wei Kong
National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China
3 shared publications - Lin Xu
School of Life Sciences, Jilin University, Changchun, P.R. China
2 shared publications - Peihu Fan
School of Life Sciences, Jilin University, Changchun 130012, China
2 shared publications - Weiheng Su
School of Life Sciences, Jilin University, Changchun 130012, China
2 shared publications
Latest Publications
- 1 January 2019
- Published by Elsevier in Antiviral Research
- Vol. 161, 108-115
A neonatal mouse model of Enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis
- 1 January 2019
- Published by Elsevier in Antiviral Research
- Vol. 161, 108-115
A neonatal mouse model of Enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis
- Open Access
Identification of Luteolin as Enterovirus 71 and Coxsackievirus A16 Inhibitors through Reporter Viruses and Cell Viability-Based Screening
Hand, foot and mouth disease (HFMD) is a common pediatric illness mainly caused by infection with enterovirus 71 (EV71) and coxsackievirus A16 (CA16). The frequent HFMD outbreaks have become a serious public health problem. Currently, no vaccine or antiviral drug for EV71/CA16 infections has been approved. In this study, a two-step screening platform consisting of reporter virus-based assays and cell viability‑based assays was developed to identify potential inhibitors of EV71/CA16 infection. Two types of reporter viruses, a pseudovirus containing luciferase-encoding RNA replicons encapsidated by viral capsid proteins and a full-length reporter virus containing enhanced green fluorescent protein, were used for primary screening of 400 highly purified natural compounds. Thereafter, a cell viability-based secondary screen was performed for the identified hits to confirm their antiviral activities. Three compounds (luteolin, galangin, and quercetin) were identified, among which luteolin exhibited the most potent inhibition of viral infection. In the cell viability assay and plaque reduction assay, luteolin showed similar 50% effective concentration (EC50) values of about 10 μM. Luteolin targeted the post-attachment stage of EV71 and CA16 infection by inhibiting viral RNA replication. This study suggests that luteolin may serve as a lead compound to develop potent anti-EV71 and CA16 drugs.
Open AccessIdentification of Luteolin as Enterovirus 71 and Coxsackievirus A16 Inhibitors through Reporter Viruses and Cell Viability-Based Screening
Hand, foot and mouth disease (HFMD) is a common pediatric illness mainly caused by infection with enterovirus 71 (EV71) and coxsackievirus A16 (CA16). The frequent HFMD outbreaks have become a serious public health problem. Currently, no vaccine or antiviral drug for EV71/CA16 infections has been approved. In this study, a two-step screening platform consisting of reporter virus-based assays and cell viability‑based assays was developed to identify potential inhibitors of EV71/CA16 infection. Two types of reporter viruses, a pseudovirus containing luciferase-encoding RNA replicons encapsidated by viral capsid proteins and a full-length reporter virus containing enhanced green fluorescent protein, were used for primary screening of 400 highly purified natural compounds. Thereafter, a cell viability-based secondary screen was performed for the identified hits to confirm their antiviral activities. Three compounds (luteolin, galangin, and quercetin) were identified, among which luteolin exhibited the most potent inhibition of viral infection. In the cell viability assay and plaque reduction assay, luteolin showed similar 50% effective concentration (EC50) values of about 10 μM. Luteolin targeted the post-attachment stage of EV71 and CA16 infection by inhibiting viral RNA replication. This study suggests that luteolin may serve as a lead compound to develop potent anti-EV71 and CA16 drugs.
- Open Access
- 6 August 2013
- Published by Springer Nature in Virology Journal
- Vol. 10 (1) , 250
Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2
Human enterovirus type 71 (EV71) and Coxsackievirus A group type 16 (CA16) belong to human Enterovirus species A of the family Picornaviridae. These viruses are recognized as the major pathogens responsible for epidemics of hand-foot-mouth disease (HFMD), which presents with fever and vesicular eruptions of palms, soles of the feet or mouth. Human scavenger receptor class B, member 2 (SCARB2) has been identified as the receptor for both EV71 and CA16, as overexpression of SCARB2 in cells can enhance virus replication significantly.
- 6 August 2013
- Published by Springer Nature in Virology Journal
- Vol. 10 (1) , 250
Open AccessEstablishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2
Human enterovirus type 71 (EV71) and Coxsackievirus A group type 16 (CA16) belong to human Enterovirus species A of the family Picornaviridae. These viruses are recognized as the major pathogens responsible for epidemics of hand-foot-mouth disease (HFMD), which presents with fever and vesicular eruptions of palms, soles of the feet or mouth. Human scavenger receptor class B, member 2 (SCARB2) has been identified as the receptor for both EV71 and CA16, as overexpression of SCARB2 in cells can enhance virus replication significantly.
- 1 February 2013
- Published by Elsevier in Journal of Virological Methods
- Vol. 187 (2) , 362-367
Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum
- 1 February 2013
- Published by Elsevier in Journal of Virological Methods
- Vol. 187 (2) , 362-367
Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum